Lawn ND, Fletcher DD, Henderson RD, et al. Anticipating mechanical ventilation in Guillain-Barré syndrome. Arch Neurol. 2001;58:893-898.
Dyck PJ, Dyck PJ, Grant IA, et al. Ten steps in characterizing and diagnosing patients with peripheral neuropathy. Neurology. 1996;47:10-17.
1. Italian General Practitioner Study Group (IGPSG). Chronic symmetric symptomatic polyneuropathy in the elderly: a field screening investigation in two Italian regions. I. Prevalence and general characteristics of the sample. Neurology. 1995;45:1832-1836.
2. Bharucha NE, Bharucha AE, Bharucha EP. Prevalence of peripheral neuropathy in the Parsi community of Bombay. Neurology. 1991;41:1315-1317.
3. Savettieri G, Rocca WA, Salemi G, Meneghini F, et al. Prevalence of diabetic neuropathy with somatic symptoms: a door-to-door survey in two Sicilian municipalities. Sicilian Neuro-Epidemiologic Study (SNES) Group. Neurology. 1993;43:1115-1120.
4. Dyck PJ, Kratz KM, Karnes JL, et al. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology. 1993 Apr;43(4):817-24.
5. Simpson DM, Kitch D, Evans SR et al. HIV neuropathy natural history cohort study: assessment measures and risk factors. Neurology. 2006;66:1679-1687.
6. Novella SP, Inzucchi SE, Goldstein JM: The frequency of undiagnosed diabetes and impaired glucose tolerance in patients with idiopathic sensory neuropathy. Muscle Nerve. 2001;24:1229-1231.
7. Singleton JR, Smith AG, Bromberg MB. Painful sensory polyneuropathy associated with impaired glucose tolerance. Muscle Nerve. 2001;24:1225-1228.
8. Tagliati M, Grinnel J, Godbold J, et al. Peripheral nerve function in HIV infection: clinical, electrophysiologic, and laboratory findings. Arch Neurol. 1999;56:84-89.
9. Childs EA, Lyles RH, Selnes OA, et al. Plasma viral load and CD4 lymphocytes predict HIV-associated dementia and sensory neuropathy. Neurology. 1999;52:607-613.
10. Notermans NC, Wokke JHJ, Lokhorst HM, et al. Polyneuropathy associated with monoclonal gammopathy of undetermined significance. Brain. 1994;117:1385-1393.
11. Lawn ND, Fletcher DD, Henderson RD, et al. Anticipating mechanical ventilation in Guillain-Barré syndrome. Arch Neurol. 2001;58:893-898.
12. McLeod JG. Investigation of peripheral neuropathy. J Neurol Neurosurg Psychiatry. 1995;58:274-283.
13. Dyck PJ, Dyck PJ, Grant IA, et al. Ten steps in characterizing and diagnosing patients with peripheral neuropathy. Neurology. 1996;47:10-17.
14. Barohn RJ. Approach to peripheral neuropathy and neuronopathy. Semin Neurol. 1998;18:7-18.
15. Wolfe GI, Baker NS, Amato AA, et al. Chronic cryptogenic sensory polyneuropathy: clinical and laboratory characteristics. Arch Neurol. 1999;56:540-547.
16. Suarez GA, Chalk CH, Russell JW, et al. Diagnostic accuracy and certainty from sequential evaluations in peripheral neuropathy. Neurology. 2001;57:1118-1120.
17. Rosenberg NR, Portegies P, de Visser M, et al. Diagnostic investigation of patients with chronic polyneuropathy: evaluation of a clinical guideline. J Neurol Neurosurg Psychiatry. 2001;71:205-209.
18. England JD, Gronseth GS, Franklin G, et al; American Academy of Neurology. Practice Parameter: evaluation of distal symmetric polyneuropathy: role of laboratory and genetic testing (an evidence-based review). Report of the American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine, and American Academy of Physical Medicine and Rehabilitation. Neurology. 2009;72:185-192.
19. Hughes RA. Peripheral neuropathy. BMJ. 2002;324:466-469.
20. England JD, Gronseth GS, Franklin G, et al; American Academy ofNeurology; American Association of Neuromuscular and Electrodiagnostic Medicine; American Academy of Physical Medicine and Rehabilitation. Evaluation of distal symmetric polyneuropathy: the role of laboratory and genetic testing (an evidence-based review). Muscle Nerve. 2009;39:116-125.
21. American Diabetes Association. Position statement: diagnosis and classification of diabetes mellitus. Diabetes Care. 2004;27:S5-S10.
22. England JD, Gronseth GS, Franklin G, et al; American Academy of Neurology. Practice Parameter: evaluation of distal symmetric polyneuropathy: role of autonomic testing, nerve biopsy, and skin biopsy (an evidence-based review). Report of the American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine, and American Academy of Physical Medicine and Rehabilitation. Neurology. 2009;72:177-184.
23. Mindel A, Tenant-Flowers M. ABC of AIDS: Natural history and management of early HIV infection. BMJ. 2001;322:1290-1293.
24. Vitali C, Moutsopoulos HM, Bombardieri S. The European Community Study Group on diagnostic criteria for Sjögren's syndrome. Oral involvement in Sjögren's syndrome. Sensitivity and specificity of tests for ocular and oral involvement in Sjogren's syndrome. Ann Rheum Dis. 1994;53;637-647.
25. Carsons S. A review and update of Sjogren's syndrome: manifestations, diagnosis and treatment. Am J Manag Care. 2001;7(suppl 14):S433-S443.
26. Brennan MT, Sankar V, Leakan RA, at al. Risk factors for positive minor salivary gland biopsy findings in Sjogren's syndrome and dry mouth patients. Arthritis Rheum. 2002;47:189-195.
27. American College of Rheumatology and HOC committee on systemic lupus erythematosus guidelines. Guidelines for the referral and management of systemic lupus erythematosus in adults. Arthritis Rheum. 1999;42:1785-1796.
28. Falk RH, Comenzo RL, Skinner M. Review article: medical progress. The systemic amyloidoses. N Eng J Med. 1997;337:898-909.
29. Kumar N, Gross JB Jr, Ahlskog JE: Myelopathy due to copper deficiency. Neurology. 2003;61:273-274.
30. Brady RO, Schiffmann R. Clinical features of and recent advances in therapy for Fabry Disease. JAMA. 2000;284:2771-2775.
31. Wierzbicki AS, Lloyd MD, Schofield CJ, Feher MD et al. Refusm disease: a peroxisomal disorder affecting phytanic acid alpha-oxidation. J Neurochem. 2002;80:727-735.
32. Sinha S, Mahadevan A, Lokesh L, et al. Tangier disease-a diagnostic challenge in countries endemic for leprosy. J Neurol Neurosurg and Psychiatry. 2004;75:301-304.
使用此内容应接受我们的免责声明。
BMJ临床实践的持续改进离不开您的帮助和反馈。如果您发现任何功能问题和内容错误,或您对BMJ临床实践有任何疑问或建议,请您扫描右侧二维码并根据页面指导填写您的反馈和联系信息*。一旦您的建议在我们核实后被采纳,您将会收到一份小礼品。
如果您有紧急问题需要我们帮助,请您联系我们。
邮箱:bmjchina.support@bmj.com
电话:+86 10 64100686-612
*您的联系信息仅会用于我们与您确认反馈信息和礼品事宜。
BMJ临床实践官方反馈平台